Forward Pharma A/S (FWP)

NASDAQ: FWP · IEX Real-Time Price · USD
4.48
+0.18 (4.19%)
At close: Jun 24, 2022 4:00 PM
4.23
-0.25 (-5.58%)
After-hours: Jun 24, 2022 4:00 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018201720162015201420132012 2011 - 2012
Revenue
00001,25000000
Upgrade
Cost of Revenue
00002500000
Upgrade
Gross Profit
00001,22500000
Upgrade
Selling, General & Admin
3.653.064.239.5417.1114.3815.859.151.010.93
Upgrade
Research & Development
0.230.331.052.7520.541.0533.7310.558.024.45
Upgrade
Operating Expenses
3.873.395.2812.2837.655.4349.5819.79.035.37
Upgrade
Operating Income
-3.87-3.39-5.28-12.281,187.4-55.43-49.58-19.7-9.03-5.37
Upgrade
Interest Expense / Income
00000000.420.080
Upgrade
Other Expense / Income
-1.983.06-1.06-3.362.91-0.9-12.24-0.856.6917.11
Upgrade
Pretax Income
-1.89-6.45-4.22-8.931,184.49-54.54-37.34-19.27-15.79-22.48
Upgrade
Income Tax
000-0.2267.4-21.2-0.34-0.25-0.10
Upgrade
Net Income
-1.89-6.45-4.22-8.72917.09-33.34-37-19.02-15.7-22.48
Upgrade
Net Income Common
-1.89-6.45-4.22-8.72917.09-33.34-37-19.02-15.7-22.48
Upgrade
Shares Outstanding (Basic)
969595944747474545-
Upgrade
EPS (Basic)
-0.28-0.98-0.56-1.2633.74-0.84-0.98-25.06-7.56-11.20
Upgrade
EPS (Diluted)
-0.28-0.98-0.56-1.2632.20-0.84-0.98-25.06-7.56-11.20
Upgrade
Free Cash Flow Per Share
-0.34-0.84-0.33-2.19279.13-10.20-10.69-2.96-2.61-
Upgrade
Dividend Per Share
----161.86-----
Upgrade
Gross Margin
----98.00%-----
Upgrade
Operating Margin
----94.99%-----
Upgrade
Profit Margin
----73.37%-----
Upgrade
Free Cash Flow Margin
----75.20%-----
Upgrade
Effective Tax Rate
0.00%0.00%0.00%2.29%22.57%38.88%0.90%1.30%0.61%0.00%
Upgrade
EBITDA
-1.89-6.45-4.22-8.921,184.72-54.43-37.3-18.85-15.71-22.48
Upgrade
EBITDA Margin
----94.78%-----
Upgrade
Depreciation & Amortization
0000.010.230.110.04000
Upgrade
EBIT
-1.89-6.45-4.22-8.931,184.49-54.54-37.34-18.85-15.72-22.48
Upgrade
EBIT Margin
----94.76%-----
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).